Búsqueda | Portal de Búsqueda de la BVS Colombia

1.

The Myriad Decision at 10.

Sherkow, Jacob S; Cook-Deegan, Robert; Greely, Henry T.

Annu Rev Genomics Hum Genet ; 2024 Feb 29.

Artículo en Inglés | MEDLINE | ID: mdl-38424474

2.

Ethical, legal, and social issues in the Earth BioGenome Project.

Sherkow, Jacob S; Barker, Katharine B; Braverman, Irus; Cook-Deegan, Robert; Durbin, Richard; Easter, Carla L; Goldstein, Melissa M; Hudson, Maui; Kress, W John; Lewin, Harris A; Mathews, Debra J H; McCarthy, Catherine; McCartney, Ann M; da Silva, Manuela; Torrance, Andrew W; Greely, Henry T.

Proc Natl Acad Sci U S A ; 119(4)2022 01 25.

Artículo en Inglés | MEDLINE | ID: mdl-35042809

3.

Preprint servers and patent prior art: Preprints can jeopardize the patentability of an invention: Preprints can jeopardize the patentability of an invention.

Sherkow, Jacob S.

EMBO Rep ; 23(2): e54439, 2022 02 03.

Artículo en Inglés | MEDLINE | ID: mdl-34914166

4.

Models of Technology Transfer for Genome-Editing Technologies.

Graff, Gregory D; Sherkow, Jacob S.

Annu Rev Genomics Hum Genet ; 21: 509-534, 2020 08 31.

Artículo en Inglés | MEDLINE | ID: mdl-32151165

5.

The History of Patenting Genetic Material.

Sherkow, Jacob S; Greely, Henry T.

Annu Rev Genet ; 49: 161-82, 2015.

Artículo en Inglés | MEDLINE | ID: mdl-26442843

6.

FAMILIAL SEARCHES, THE FOURTH AMENDMENT, AND GENOMIC CONTROL.

Sherkow, Jacob S; Ram, Natalie; Gunter, Carl A.

South Calif Law Rev ; 96(PS1): 1-14, 2022.

Artículo en Inglés | MEDLINE | ID: mdl-37928339

7.

Fortune and hindsight: gene patents' muted effect on medical practice.

Sherkow, Jacob S; Abbott, Ryan.

Br Med Bull ; 126(1): 37-45, 2018 06 01.

Artículo en Inglés | MEDLINE | ID: mdl-29608656

8.

Assessing-and Extending-California's Insulin Manufacturing Initiative.

Sherkow, Jacob S; Adashi, Eli Y; Cohen, I Glenn.

JAMA ; 329(7): 533-534, 2023 02 21.

Artículo en Inglés | MEDLINE | ID: mdl-36656599

9.

Regulating Direct-to-Consumer Polygenic Risk Scores.

Sherkow, Jacob S; Park, Jin K; Lu, Christine Y.

JAMA ; 330(8): 691-692, 2023 08 22.

Artículo en Inglés | MEDLINE | ID: mdl-37535347

10.

CRISPR: Pursuit of profit poisons collaboration.

Sherkow, Jacob S.

Nature ; 532(7598): 172-3, 2016 Apr 14.

Artículo en Inglés | MEDLINE | ID: mdl-27075081

11.

CRISPR, Patents, and the Public Health.

Sherkow, Jacob S.

Yale J Biol Med ; 90(4): 667-672, 2017 12.

Artículo en Inglés | MEDLINE | ID: mdl-29259531

12.

Patent Law's Reproducibility Paradox.

Sherkow, Jacob S.

Duke Law J ; 66(4): 845-911, 2017 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-28117563

13.

Governing Human Germline Editing Through Patent Law.

Sherkow, Jacob S; Adashi, Eli Y; Cohen, I Glenn.

JAMA ; 326(12): 1149-1150, 2021 Sep 28.

Artículo en Inglés | MEDLINE | ID: mdl-34459849

14.

Patent Eligibility Reform and the Public Health.

Sherkow, Jacob S.

Milbank Q ; 97(3): 654-658, 2019 09.

Artículo en Inglés | MEDLINE | ID: mdl-31321802

15.

Inventive steps: the CRISPR patent dispute and scientific progress: The recent patent decisions about CRISPR tell us a lot about how advances in biology are actually made-and how they are not.

Sherkow, Jacob S.

EMBO Rep ; 18(7): 1047-1051, 2017 07.

Artículo en Inglés | MEDLINE | ID: mdl-28536246

16.

Immaculate Conception? Priority and Invention in the CRISPR Patent Dispute.

Sherkow, Jacob S.

CRISPR J ; 5(2): 174-180, 2022 04.

Artículo en Inglés | MEDLINE | ID: mdl-35438517

17.

Handle with Care: The WHO Report on Human Genome Editing.

Cohen, I Glenn; Sherkow, Jacob S; Adashi, Eli Y.

Hastings Cent Rep ; 52(2): 10-14, 2022 03.

Artículo en Inglés | MEDLINE | ID: mdl-35476355

18.

Governance Choices of Genome Editing Patents.

Scheinerman, Naomi; Sherkow, Jacob S.

Front Polit Sci ; 32021.

Artículo en Inglés | MEDLINE | ID: mdl-35557745

19.

Biological controls for standardization and interpretation of adaptive immune receptor repertoire profiling.

Trück, Johannes; Eugster, Anne; Barennes, Pierre; Tipton, Christopher M; Luning Prak, Eline T; Bagnara, Davide; Soto, Cinque; Sherkow, Jacob S; Payne, Aimee S; Lefranc, Marie-Paule; Farmer, Andrew; Bostick, Magnolia; Mariotti-Ferrandiz, Encarnita.

Elife ; 102021 05 26.

Artículo en Inglés | MEDLINE | ID: mdl-34037521

20.

Reactions to the National Academies/Royal Society Report on Heritable Human Genome Editing.

Angrist, Misha; Barrangou, Rodolphe; Baylis, Françoise; Brokowski, Carolyn; Burgio, Gaetan; Caplan, Arthur; Chapman, Carolyn Riley; Church, George M; Cook-Deegan, Robert; Cwik, Bryan; Doudna, Jennifer A; Evans, John H; Greely, Henry T; Hercher, Laura; Hurlbut, J Benjamin; Hynes, Richard O; Ishii, Tetsuya; Kiani, Samira; Lee, LaTasha Hoskins; Levrier, Guillaume; Liu, David R; Lunshof, Jeantine E; Macintosh, Kerry Lynn; Mathews, Debra J H; Meslin, Eric M; Mills, Peter H R; Montoliu, Lluis; Musunuru, Kiran; Nicol, Dianne; O'Neill, Helen; Qiu, Renzong; Ranisch, Robert; Sherkow, Jacob S; Soni, Sheetal; Terry, Sharon; Topol, Eric; Williamson, Robert; Zhang, Feng; Davies, Kevin.

CRISPR J ; 3(5): 332-349, 2020 10.

Artículo en Inglés | MEDLINE | ID: mdl-33095048

Portal de Búsqueda de la BVS Colombia

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

The Myriad Decision at 10.

Ethical, legal, and social issues in the Earth BioGenome Project.

Preprint servers and patent prior art: Preprints can jeopardize the patentability of an invention: Preprints can jeopardize the patentability of an invention.

Models of Technology Transfer for Genome-Editing Technologies.

The History of Patenting Genetic Material.

FAMILIAL SEARCHES, THE FOURTH AMENDMENT, AND GENOMIC CONTROL.

Fortune and hindsight: gene patents' muted effect on medical practice.

Assessing-and Extending-California's Insulin Manufacturing Initiative.

Regulating Direct-to-Consumer Polygenic Risk Scores.

CRISPR: Pursuit of profit poisons collaboration.

CRISPR, Patents, and the Public Health.

Patent Law's Reproducibility Paradox.

Governing Human Germline Editing Through Patent Law.

Patent Eligibility Reform and the Public Health.

Inventive steps: the CRISPR patent dispute and scientific progress: The recent patent decisions about CRISPR tell us a lot about how advances in biology are actually made-and how they are not.

Immaculate Conception? Priority and Invention in the CRISPR Patent Dispute.

Handle with Care: The WHO Report on Human Genome Editing.

Governance Choices of Genome Editing Patents.

Biological controls for standardization and interpretation of adaptive immune receptor repertoire profiling.

Reactions to the National Academies/Royal Society Report on Heritable Human Genome Editing.